
Overview
Genvita is a biotechnology company that develops and creates biodegradable materials for medical applications, including partially biodegradable medical masks designed to protect against viruses and bacteria. The company also focuses on innovative biotechnological and agrotechnical solutions for the textile and herbal industries, as well as the cultivation of new plant species. Their products are intended for distribution to pharmaceutical wholesalers, pharmacies, and hospitals.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Industry
Bank accounts
Registered as a VAT taxpayer on 2020-06-11. Active
97 1050 1025 1000 0090 3220 8051
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 24, 2022 | Aid for research and development projects: industrial research | $316.2K$316,222 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jan 24, 2022 | Aid for research and development projects: experimental development | $140.9K$140,854 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jan 24, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $52,349$52,349 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-10-01 | Opracowanie biodegradowalnej maseczki typu drugiego składającej się z włókien naturalnych | $1.2M$1,208,838 | Program Operacyjny Inteligentny Rozwój |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Rafał Andrzej Perz (40) | 30 | $405.19 | 30% |
Joanna Ratajczak (38) | 70 | $945.43 | 70% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Rafał Andrzej Perz (40) | Shareholder of a limited liability company, 1500.0 PLN | |
Joanna Ratajczak (38) | Shareholder of a limited liability company, 3500.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Biovicosp. z o.o. | $32,716,605.20 | biovico.com | ||
| ChitomedP.S.A. | $206,587.41 | chitomed.com | ||
| Medintechsp. z o.o. | $16,560.95 | medintech.pl | ||
| BIO 3d Solutionssp. z o.o. | $11,692.51 | bio3dsolutions.com |
Change history
| Date | Event | |
|---|---|---|
| 2022-05-16 | Address change (Ul. Williama Heerleina Lindleya 16, 02-013, Warszawa → Aleja Jana Pawła Ii 27, 00-867, Warszawa) | |
| 2022-05-16 | PKD change (Removed: 47.74.Z, 47.91.Z, 68.20.Z, 82.92.Z; Added: 71.12.Z, 71.20.B, 74.90.Z) | |
| 2020-04-24 | Entered in the register |
FAQ
Last updated: 2026-07-16